- Home
- IMMX vs PRTS Comparison
IMMX vs PRTS Comparison
Compare IMMX & PRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- PRTS
- Stock Information
- Founded
- IMMX 2014
- PRTS 1995
- Country
- IMMX United States
- PRTS United States
- Employees
- IMMX N/A
- PRTS N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- PRTS Auto & Home Supply Stores
- Sector
- IMMX Health Care
- PRTS Consumer Discretionary
- Exchange
- IMMX Nasdaq
- PRTS Nasdaq
- Market Cap
- IMMX 55.3M
- PRTS 52.5M
- IPO Year
- IMMX 2021
- PRTS 2007
- Fundamental
- Price
- IMMX $1.76
- PRTS $0.94
- Analyst Decision
- IMMX Strong Buy
- PRTS Buy
- Analyst Count
- IMMX 1
- PRTS 3
- Target Price
- IMMX $7.00
- PRTS $1.60
- AVG Volume (30 Days)
- IMMX 83.5K
- PRTS 394.4K
- Earning Date
- IMMX 03-28-2025
- PRTS 03-06-2025
- Dividend Yield
- IMMX N/A
- PRTS N/A
- EPS Growth
- IMMX N/A
- PRTS N/A
- EPS
- IMMX N/A
- PRTS N/A
- Revenue
- IMMX N/A
- PRTS $611,705,000.00
- Revenue This Year
- IMMX N/A
- PRTS N/A
- Revenue Next Year
- IMMX $600.00
- PRTS $1.58
- P/E Ratio
- IMMX N/A
- PRTS N/A
- Revenue Growth
- IMMX N/A
- PRTS N/A
- 52 Week Low
- IMMX $1.26
- PRTS $0.68
- 52 Week High
- IMMX $3.80
- PRTS $2.68
- Technical
- Relative Strength Index (RSI)
- IMMX 31.71
- PRTS 35.16
- Support Level
- IMMX $1.85
- PRTS $1.04
- Resistance Level
- IMMX $2.14
- PRTS $1.06
- Average True Range (ATR)
- IMMX 0.12
- PRTS 0.07
- MACD
- IMMX -0.02
- PRTS -0.02
- Stochastic Oscillator
- IMMX 8.43
- PRTS 1.45
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.